Treatment of Antiphospholipid Syndrome in Systemic Lupus Erythematosus with Antiphospholipid Antibody Positivity and No History of Thrombosis

Patients with systemic lupus erythematosus (SLE) who test positive for antiphospholipid antibodies but have no history of thrombosis and no history of pregnancy complications form a distinct group requiring risk-stratified prophylactic management.

Clinical Scenario

Systemic lupus erythematosus with confirmed antiphospholipid antibody positivity. No prior thrombotic events. No prior pregnancy complications. Management is guided by the patient's antiphospholipid antibody risk profile.

Treatment Approach

Current evidence supports prophylactic therapy with low-dose aspirin in this setting. The full risk-stratified protocol — including the complete criteria and evidence-based regimen — is available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

In patients with SLE and no history of thrombosis or pregnancy complications: With high-risk aPL profile, prophylactic treatment with LDA is recommended.
With low-risk aPL profile, prophylactic treatment with LDA may be considered.

DOI: 10.1136/annrheumdis-2019-215213

View source ↗